RXi Pharmaceuticals to Present Data Demonstrating the Robust Performance of its RNAi Therapeutics...

Nov 3, 2009 11 related

RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that Dmitry Samarsky,... [read full story]

Add Comment

There are also 11 related articles

View all news articles about*:

Ambulatory Biopharmaceuticals Care Conferences Corporation Discoveries Health Inventions Medical Medicines Pharmaceuticals Remedies Research RXi Scientific

*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

Send to a friend | Bookmark with

NewstinMap

Click to Open NewstinMap —

Visual Navigation

My Newstin

Context

Intelligent Data Fusion

About Us

Visit our corporate homepage to learn more about our company and products.

RXi Pharmaceuticals to Present Data Demonstrating the Robust Performance of its RNAi Therapeutics...

View other selected articles:

Asian shares sold down on Dubai fears, yen surge (at MarketWatch)

Sony Blames Samsung For Their Bravia TV Problems

Samsung SMX C10

Nigeria: Deregulation Tango - Lamentations of Dr. Barkindo (NNPC/GMD)

International Editions